Caegis Pharma (OPC) Private Limited
About Caegis Pharma (OPC) Private Limited
Data last updated:
Caegis Pharma (OPC) Private Limited is a one person company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 08 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018OPC333589. Its GSTIN is 07AAHCC5648N1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by director Reena Bhagat.
Its last annual general meeting (AGM) was held on 26 September 2019, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop 301 3rd Floor Mlu Plot No 10 Sec 12 Vardhman Gee Dee Plaza, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.74 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹12,296 (net margin -0.7%) and EBITDA of ₹8,655 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Caegis Pharma (OPC) Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop 301 3rd Floor Mlu Plot No 10 Sec 12 Vardhman Gee Dee Plaza, New Delhi, Delhi, India – 110078
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Caegis Pharma (OPC) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Caegis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Caegis Pharma (OPC) Private Limited, buy the company report.
Financials of Caegis Pharma (OPC) Private Limited
FY 2024 filings availableCaegis Pharma (OPC) Private Limited reported revenue of ₹16.74 Lakh (down 28% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA rose 123% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,655 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12,296 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Caegis Pharma (OPC) Private Limited, buy the company report.
Board of directors of Caegis Pharma (OPC) Private Limited
Caegis Pharma has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reena Bhagat Also directs: PN Cradle and Catalyst LLP, Glocal Hub of De Mie Private Limited | Director | 08 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Caegis Pharma (OPC) Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dev Bhoomi Recycling Private Limited | ₹16.75 Lakh (FY 2024) | -79.0% | Dehradun, Uttarakhand, India | |||
| Wemron Trading (OPC) Private Limited | ₹16.75 Lakh (FY 2022) | 0.0% | Patna, Bihar, India | |||
| Rexilo Pharma Private Limited | ₹16.74 Lakh (FY 2023) | Howrah, West Bengal, India | ||||
| Excellent Exim & Commerce Pvt. Ltd. | ₹16.74 Lakh (FY 2024) | 10756.0% | Kolkata, West Bengal, India | |||
| Vedansh Hi-Tech Engineers Private Limited | ₹16.74 Lakh (FY 2022) | 345.0% | Nagpur, Maharashtra, India | |||
| Caegis Pharma (OPC) Private Limitedthis company | ₹16.74 Lakh (FY 2024) | -₹12,296 | -0.7% | -28.0% | New Delhi, Delhi, India | |
| Pureorganics and Foods India Private Limited | ₹16.73 Lakh (FY 2025) | 43.0% | New Delhi, Delhi, India | |||
| Shulyn Realty Private Limited | ₹16.73 Lakh (FY 2024) | Gautam Budh Nagar, Uttar Pradesh, India | ||||
| Skygoal Marketing and Services Private Limited | ₹16.73 Lakh (FY 2021) | 97.0% | Jagatsinghapur, Odisha, India | |||
| Synergy Textiles Limited. | ₹16.73 Lakh (FY 2019) | 3.0% | New Delhi, Delhi, India | |||
| Progetto Cooling Technologies Private Limited | ₹16.73 Lakh (FY 2024) | -41.0% | Dewas, Madhya Pradesh, India |
To see the full peer comparison of Caegis Pharma (OPC) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Caegis Pharma (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Caegis Pharma (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Caegis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCC5648N1Z4 | Delhi | Active | 29 Jun 2018 |
To see the full GST registrations and return filing status of Caegis Pharma (OPC) Private Limited, buy the company report.
Recent activity
Caegis Pharma (OPC) Private Limited has 1 board change on record since 2018: 1 appointment. The latest: Reena Bhagat was appointed as Director on 08 May 2018.
Frequently asked questions
Caegis Pharma is an active company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 08 May 2018 (8+ years old) and is registered under CIN U51909DL2018OPC333589.
Caegis Pharma has 1 current director:
- Reena Bhagat - Director
The latest financial statements of Caegis Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 26 September 2019. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Caegis Pharma is 07AAHCC5648N1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Caegis Pharma is U51909DL2018OPC333589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caegis Pharma was incorporated on 08 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Caegis Pharma by revenue are Dev Bhoomi Recycling Private Limited, Wemron Trading (OPC) Private Limited, Rexilo Pharma Private Limited, Excellent Exim & Commerce Pvt. Ltd, Vedansh Hi-Tech Engineers Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Reena Bhagat was appointed as Director on 08 May 2018.
The registered office of Caegis Pharma is at Shop 301 3rd Floor Mlu Plot No 10 Sec 12 Vardhman Gee Dee Plaza, New Delhi, Delhi, India – 110078.
Caegis Pharma operates in the trading industry, in the specialty segment.
The compliance status of Caegis Pharma is compliant as of 08 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
